KFx Medical Closes $10 Million Series B Financing

KFx Medical, a four-year-old orthopedic-device maker from Carlsbad, CA, has closed $10 million in Series B financing.

The financing — led by Alloy Ventures, and participated in by returning investors Charter Life Sciences L.P., Arboretum Ventures, Montreux Equity Partners, and MB Venture Partners — “enables us to further our goals as we begin the distribution of the most secure rotator cuff repair available,” said CEO Tate Scott, in a press release.

According to KFx, over four million people seek medical advice for shoulder pain every year, and torn rotator cuffs alone account for more than 500,000 surgeries annually and traditionally require many weeks of rehabilitation. While minimally invasive techniques have improved things, causing patients less pain and allowing them to regain full range of motion more quickly, many of these techniques require surgeons to have advanced videoscopic skills.

In contrast, KFx’s SutureCross Knotless Anatomic Fixation System, for double row arthroscopic rotator cuff repair, is simple, requiring no knot tying or suture passing. The device received 501(k) clearance from FDA in August 2006.

The comments are closed.